HOME >> MEDICINE >> NEWS
New NCI grant will support Jefferson trial to study test to diagnose colorectal cancer spread

if disease spread to the lymph nodes and then follow those patients to see how they do clinically during the next five years.

"We expect to find the GCC-RT-PCR analysis will identify patients who have tiny amounts of cancer in the lymph nodes that were undetected by histopathology," he says. "The pathology will be done in parallel with testing for GCC. We believe that the patients who are histopathology negative but GCC positive will do worse in terms of clinical progression - they will develop recurrent disease that was missed the first time."

In a previous trial, Dr. Waldman and his Jefferson co-workers examined 21 colorectal cancer patients. One group of 11 patients had been disease-free for at least six years and deemed "cured." The other group of 10 patients developed recurrent disease within three years after cancer surgery. The latter had been told initially that they had no signs of cancer in their lymph nodes after surgery, meaning their cancer had not spread.

When pathologists examined lymph node samples of each patient for the presence of GCC, they found the disease-free patients' lymph nodes showed no signs of the marker. Conversely, GCC was present in every patient whose cancer had returned.

"The earlier trial was on a small scale, and until you do this [larger] trial, you really can't be sure if testing for GCC is as good as it appears," he says. "This is a prospective trial in which patients are staged and then we see how they do. In the past, the study was retrospective - we knew what happened to the patient. There's no bias in this trial - we don't know what will happen."

Dr. Waldman isn't sure that one marker will necessarily catch all colorectal cancer that has spread elsewhere in the body, noting eventually, a panel of markers may be used. "We think GCC represents an order of improvement over what is done now. Perhaps adding other markers will make it even better."

To participate in the trial, a patient must have a
'"/>

Contact: Steve Benowitz
steven.benowitz@mail.tju.edu
215-955-5291
Thomas Jefferson University
20-Jun-2002


Page: 1 2 3 4

Related medicine news :

1. UNH launches 2nd spinout company with NIH grants
2. Mailman School of Public Health receives Manhattan Tobacco Cessation Center grant
3. $4 million grant boosts University of Michigan campaign for a new childrens hospital
4. Disease testing for immigrants: Discrimination disguised as public health policy
5. NASA awards $9.8 million NSCOR grant to UT Southwestern to study effects of space radiation exposure
6. NYU Child Study Center receives grant from the American Red Cross September 11 recovery program
7. US FDA grants full approval to DOXIL(R) following submission of phase III data
8. Dartmouth awarded $21.8 million NSF grant
9. ASGE announces grant recipients in annual research awards program
10. Insulin resistance intervention after stroke focus of $33 million grant
11. Mayo Clinic Cancer Center receives SPORE grant for brain cancer research from NCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/19/2019)... ... February 19, 2019 , ... ... stigma in pregnant and postpartum women, a team led by a Worcester Polytechnic ... postpartum often show increased depressive symptoms, greater weight gain during pregnancy, and weight ...
(Date:2/19/2019)... ... February 19, 2019 , ... Landscape Structures Inc., a Delano, Minn.-based commercial ... to be a stunning and fun addition to any play space. Spinning is one ... Curva™ Spinners will provide kids’ brains with valuable equilibrium information. , Whether park and ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... experience to The Oncology Institute of Hope and Innovation. , Dr. Lombardi completed ... cum laude. He received his medical degree from the University of Rochester School ...
(Date:2/19/2019)... ... February 19, 2019 , ... ClearHealth ... to Foley & Lardner LLP, as Recognized Consultants. The CHQI Recognized Consultant Program ... in pursuing CHQI accreditation. , Ms. Wein and Mr. Einhorn are part ...
(Date:2/19/2019)... Fla. (PRWEB) , ... February 18, 2019 , ... ... in the nation to test the PathO3Gen Solutions Footwear Sanitizing Stations to maximize ... Solestice 3/15 TechnologyTM to kill superbugs such as MRSA and C. difficile, which ...
Breaking Medicine News(10 mins):
(Date:2/19/2019)... (PRWEB) , ... February 19, ... ... and infrastructure solutions provider for global service providers, enterprises, and developers, announced ... orchestration platform with the Arvizio MR Studio mixed reality visualization and collaboration ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... for Stage IV metastatic breast cancer (MBC), announces the opening of the 2019 ... Fairchild, “In honor of our 10-year anniversary, we are excited to announce we ...
(Date:2/19/2019)... ... February 19, 2019 , ... ... completed his new book “Live Hard Die Young.” Dr. Oexner was the first ... medicine, therapeutic exercise physiology, and nutritional counseling. Dr. Oexner was a supervisor on ...
Breaking Medicine Technology:
Cached News: